Skip to content
MarketScale
‹ Back to IndustriesHealthcare

What It’s Really Like To Live With Ulcerative Colitis – A Candid Patient Post

My name is Michaella. I am a 22-year-old lady from Western Massachusetts who got diagnosed with Ulcerative Colitis when I was in 8th grade, nine years ago. When I first started feeling symptoms, I thought I had an allergy to dairy, since dairy seemed to trigger abdominal pain and frequent bathroom visits. Around the holidays…

This story was produced through MarketScale. See how Healthcare teams put it to work with Executive Thought Leadership.

Share

Get featured

Want to get featured in MarketScale Healthcare?

Create a free MarketScale workspace and get your company's expertise featured across our Healthcare coverage. No credit card, no demo required.

Request an invite

My name is Michaella. I am a 22-year-old lady from Western Massachusetts who got diagnosed with Ulcerative Colitis when I was in 8th grade, nine years ago. When I first started feeling symptoms, I thought I had an allergy to dairy, since dairy seemed to trigger abdominal pain and frequent bathroom visits. Around the holidays that year, I told my mom how I was feeling. We went to see my primary care doctor—and I’m glad that we did.

The next day, a Saturday, my primary care physician called to tell my parents I needed to go to the emergency room immediately. My inflammation levels were through the roof.

Introducing a diagnosis—and needle phobia

Starting the minute I walked through the doors of the ER, I was regularly poked with needles to administer fluids and steroids, and conduct blood work. During this time in the hospital, I experienced at least two needle pokes a day. My veins were collapsing due to anemia, which made the situation even worse. All of these pokes caused bruises from my armpits to my wrists by the time my weeklong visit was up. This is when, understandably, my fear of needles began. All the needles required at that time for IV or blood drawing caused nerve damage in my arms.

When I was a sophomore in college, I was prescribed a biologic, which came with an auto injector. I went to my doctor’s office to get the starter dose and learn how to inject myself. They gave me the tester pen and I was good at it. I felt like I could do it myself.

I needed to be administered four starter doses during my first visit. One shot was given to me by my dad in my leg. I did one myself in the other leg, and two nurses gave me one in each arm. It felt like a thousand bee stings. I froze, and the nurses in the room had to remove my shot for me. I began to hysterically cry and hyperventilate. The nurses needed to lay me down and talk to me to calm me. Once I stopped crying, about 20 minutes later, the lead nurse said, “It should not have hurt that bad.”

Well then, I guess my pain tolerance is lower than yours, I thought to myself, raging with anger, and fearing that I would have to regularly go through the whole ordeal again. It was awful.

A new option for self-injections

Ever since then, giving myself self-injections was impossible. I had to be given a sedative to help calm me down, and I had to have my boyfriend, who is also a nurse, administer the medication to me with my mom holding my arms down. It was a tense and stressful process, to say the least. Ultimately, I refused to take the medication, and got a temporary loop ileostomy. I was on the path to a total colectomy, which is the removal of your large intestine and having a permanent ostomy.

I was recently introduced to Portal Instruments. Thanks to the company’s innovative needle-free jet injection platform, I am hopeful that someday I might be able to go back on self-injector medications and reverse my ileostomy. I might be able to live a more normal life thanks to the emphasis on an improved patient experience. A new window of opportunity has been created for me, and I can’t wait to see what the future holds.

Read more at portalinstruments.com

Your experts belong here

Every story in MarketScale Healthcare starts with a company putting its clinicians, service-line leaders, and field engineers on the record. Buyers are already reading this topic. The only question is whose experts they find.

Service-line buyers vet vendors quietly, and your clinicians become the proof they find while doing it.

Get your team featuredSee how it works15 minutes, straight to a calendar.

Follow Healthcare Insights

Get new expert content in your inbox.

Healthcare: are you visible to AI?

Before they reach out, Healthcare buyers ask AI engines which vendors to trust. See how AI describes your company today, and where competitors show up instead.

Free workspace

You just read one Healthcare expert. Your company is full of them.

This article was produced through MarketScale. The same platform turns your clinicians, service-line leaders, and field engineers into the articles, video, and social content Healthcare buyers are searching for. Create a free workspace and see it with your own people. No credit card, no demo required.

NPS +73 · 1,000+ creators · 38+ countries

What you get, free

Your own MarketScale Studio workspace
One video edit a month, on us
AI writing, editing, and publishing tools
In-platform coaching to learn the system

More Healthcare Insights

The EU’s MDR delay buys time, but it won’t clear your commissioning bottleneck

The European Commission backed extending EU MDR transition deadlines to December 2027 and December 2028, Medical Design & Outsourcing reported. It buys time, not ramp-up capacity. Design News cites digital commissioning and machine digital twins to cut “power-on” surprises and speed validation and operator training.

  • 01If an EU portfolio includes Class III, December 2027 is now the planning anchor, but the internal gating item may shift to validation capacity and automation readiness, not paperwork.
  • 02Digital commissioning is becoming a procurement spec, not a buzzword, because it lets teams run DFM/DFA learning loops before hardware is built, which Design News notes is meant to reduce machine power-on surprises.

Sep 5, 2026

HCA’s Q1 was not about volume. It was about coverage and collecting cash

HCA Healthcare reaffirmed 2026 guidance after Q1 weather and a muted respiratory season cut adjusted EBITDA by about $180 million, according to HealthLeaders and Fierce Healthcare. Payer mix shifted fast. Exchange admissions fell about 15% and uninsured admissions rose about 16%, Fierce reported.

  • 01A mild flu season can be a margin event: HCA tied a 42% drop in respiratory admissions to a roughly $180M adjusted EBITDA hit (HealthLeaders, Fierce Healthcare).
  • 02The 2026 risk is sliding from demand to coverage: HCA cited a $600M–$900M full-year EBITDA headwind from exchange-related changes, with $150M already in Q1 (HealthLeaders, Fierce Healthcare).
  • 03Supplemental payments are becoming an operating capability, not a windfall: HCA said Q1 Medicaid program net benefit was about $200M vs $80M expected (HealthLeaders, Fierce Healthcare), putting state-by-state reimbursement strategy on the CFO’s critical path.

Sep 5, 2026

Dental practice exits are turning into multi-year projects, not last-year decisions

Dental practice exits are turning into multi-year projects, not last-year decisions

Associate-led dental practice successions can take 3–5+ years. Dental Economics says associate-to-buyout timelines often run three to five-plus years. That pushes revenue-cycle controls, buy-sell terms, and tax structure earlier, before a buyer appears.

  • 01A practical benchmark is emerging for succession: bringing in an associate with intent to buy can take a minimum of three years and often more than five, according to Dental Economics.
  • 02If accounts receivable looks “high,” it may be a bookkeeping and posting problem before it is a payer problem, a revenue-cycle diagnostic Group Dentistry Now says shows up frequently at scale.
  • 03Exit planning is now an operating system project: valuation, tax positioning, and transition support belong in the same workstream, because deal structure can lock in or foreclose tax options, per Dental Economics.

Sep 4, 2026

Explore More Healthcare Insights

Read more expert perspectives from across Healthcare.

Browse Healthcare Hub

For B2B teams

Your experts could be publishing here

Stories like this one run on content MarketScale captures from real practitioners. See how your team's expertise becomes coverage in Healthcare and beyond.

Book a 15-minute demo

Or call us. No forms required. We pick up. 214-945-2512